TLDR Corticosteroid injections for hair loss may cause eye problems, so caution is needed.
This report presents two cases of central serous chorioretinopathy (CSC) following intralesional triamcinolone acetonide (IL-TAC) injections for alopecia areata (AA). A 58-year-old female developed CSC after 4 months of IL-TAC treatment, which improved upon dose reduction. A 34-year-old male developed CSC after receiving IL-TAC injections to the scalp and eyebrows, with symptoms resolving upon discontinuation of IL-TAC. These cases highlight a potential link between IL-TAC injections and CSC, suggesting the need for caution and monitoring when using corticosteroids for localized treatments. Further research is needed to understand the mechanisms and risk factors involved.
9 citations
,
September 2011 in “Cutaneous and Ocular Toxicology” Using 2% minoxidil for baldness treatment might cause vision distortion due to fluid build-up under the retina.
1 citations
,
March 2023 in “Clinical, Cosmetic and Investigational Dermatology” Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.
January 2026 in “Dermatology Practical & Conceptual” Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.
99 citations
,
July 2017 in “Clinical Reviews in Allergy & Immunology” New treatments for Alopecia Areata show promise but need to be more effective and affordable.
37 citations
,
April 2019 in “Journal of The American Academy of Dermatology” Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.
October 2024 in “Journal of Education Health and Sport” Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.
